Highly potent APIs are becoming increasingly common, and each presents their own challenges. To handle small molecule products successfully and safely, special considerations are required, such as facility design, equipment, operation, and processes.
Douglas CDMO offers integrated formulation, analytical development, manufacturing, and clinical supply solutions for highly potent products. We have the capability and procedures to handle light sensitive retinoids, hormones, cytotoxics and immunosuppressants.
To support our ability to successfully handle small molecules with high potency, we ensure strict adherence to regulatory and safety guidelines. We have recently opened a purpose-built facility with a state-of-the-art fit out to handle high potent products in segregated suites, complete with a unique waste stream to capture and manage cytotoxic waste.
From API optimization, solid state optimizations and formulation services, to drug delivery technology and final dosage form design, Douglas CDMO can help you at the earliest stages of drug development processes.
Analytical services
From raw material analysis to batch release testing, we provide thorough support for your development, manufacturing, and packaging needs.
Learn moreCommercial manufacturing
Our manufacturing sites are equipped to handle high potent APIs, while ensuring the highest quality standards for your products.
Learn more